GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Province Huinan Changlong Bio-pharmacy Co Ltd (HKSE:08049) » Definitions » Interest Expense

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Interest Expense : HK$-0.6 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Jilin Province Huinan Changlong Bio-pharmacy Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Jilin Province Huinan Changlong Bio-pharmacy Co's interest expense for the three months ended in Dec. 2023 was HK$ 1.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Jilin Province Huinan Changlong Bio-pharmacy Co's Operating Income for the three months ended in Dec. 2023 was HK$ 40.0 Mil. Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Expense for the three months ended in Dec. 2023 was HK$ 1.4 Mil. Jilin Province Huinan Changlong Bio-pharmacy Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Jilin Province Huinan Changlong Bio-pharmacy Co Interest Expense Historical Data

The historical data trend for Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Province Huinan Changlong Bio-pharmacy Co Interest Expense Chart

Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -0.85 -0.42 -0.53 -0.56

Jilin Province Huinan Changlong Bio-pharmacy Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 -0.03 -1.93 -0.03 1.42

Jilin Province Huinan Changlong Bio-pharmacy Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Province Huinan Changlong Bio-pharmacy Co  (HKSE:08049) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Expense for the three months ended in Dec. 2023 was HK$1.4 Mil. Its Operating Income for the three months ended in Dec. 2023 was HK$40.0 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was HK$78.8 Mil.

Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Jilin Province Huinan Changlong Bio-pharmacy Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.


Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Business Description

Traded in Other Exchanges
Address
625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a pharmaceutical company. It is engaged in the manufacturing and distribution of Chinese medicines and pharmaceutical products. The company sells medicines under the brand names: Changlong and Qing Tong. The group has only one business segment which is the manufacture and distribution of Chinese medicines. It derives revenue primarily from operations in the PRC.

Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Headlines

No Headlines